Lenacapavir is the first twice-daily injectable drug for the prevention of HIV infection, with 99.9% efficacy in clinical trials. Recommended by the CHMP, this treatment simplifies prevention by eliminating the need for daily tablets. In Romania, where the cost of HIV treatment is high, the new PrEP could reduce costs and improve access for vulnerable people. Approved at European level, this drug represents a significant opportunity to transform HIV prevention into public health policy.
Sources
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o şansă uriaşă pentru prevenţia HIV în România
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o șansă uriașă pentru prevenția HIV în România
Omenirea, mai aproape ca niciodată de a opri virusul HIV. Europa a autorizat tratamentul revoluționar
E.U. regulator approves injectable HIV drug that experts say could help stop transmission
EU regulator approves injectable HIV drug that experts say could help stop transmission
Latest News
23:48
Prince Harry says he would enlist in the British Army again and warns that Europe must be prepared in the face of Russia
23:16
A Romanian man without a license stole a car and fled from police in Spain / The chase ended in a head-on collision
22:50
Hakeem Jeffries will lead the U.S. House of Representatives, becoming the first Black politician to hold the position
22:21
Eugen Tomac calls for reforming public administration and says that the option of eight regions can be analyzed
22:02
Traian Băsescu says Marian Neacșu will be the “executive prime minister” of the Luca Niculescu Government
See more news